{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:08Z","timestamp":1788798428050,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00428-010-0969-6","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T08:44:47Z","timestamp":1283762687000},"page":"555-561","source":"Crossref","is-referenced-by-count":19,"title":["Cyclin D3 gene amplification in bladder carcinoma in situ"],"prefix":"10.1007","volume":"457","author":[{"given":"Antonio","family":"Lopez-Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sanchez-Carbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"de Alava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"969_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03008880802325226","volume":"Suppl 218","author":"A Lopez-Beltran","year":"2008","unstructured":"Lopez-Beltran A (2008) Bladder cancer: clinical and pathological profile. Scand J Urol Nephrol Suppl 218:95\u2013109","journal-title":"Scand J Urol Nephrol"},{"key":"969_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.6004\/jnccn.2009.0004","volume":"7","author":"N Nese","year":"2009","unstructured":"Nese N, Gupta R, Bui MH, Amin MB (2009) Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis. J Natl Compr Canc Netw 7:48\u201357","journal-title":"J Natl Compr Canc Netw"},{"key":"969_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/00365590410028692","volume":"38","author":"P Andius","year":"2004","unstructured":"Andius P, Damm O, Holm\u00e4ng S (2004) Prognostic factors in patients with carcinoma in situ treated with intravesical Bacille Calmette-Gu\u00e9rin. Scand J Urol Nephrol 38:285\u2013290","journal-title":"Scand J Urol Nephrol"},{"key":"969_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2003.09.013","volume":"45","author":"JA Witjes","year":"2004","unstructured":"Witjes JA (2004) Bladder carcinoma in situ in 2003: state of the art. Eur Urol 45:142\u2013146","journal-title":"Eur Urol"},{"key":"969_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2005.05.011","volume":"48","author":"AP Meijden van der","year":"2005","unstructured":"van der Meijden AP, Sylvester R, Oosterlinck W (2005) EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48:363\u2013371","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"969_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","volume":"66","author":"RJ Sylvester","year":"2005","unstructured":"Sylvester RJ, van der Meijden A, Witjes JA (2005) High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 66(Suppl 1):90\u2013107","journal-title":"Urology"},{"key":"969_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eururo.2006.08.037","volume":"51","author":"SF Shariat","year":"2007","unstructured":"Shariat SF, Palapattu GS, Karakiewicz PI (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51:152\u2013160","journal-title":"Eur Urol"},{"key":"969_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eursup.2008.12.004","volume":"Suppl 8","author":"R Montironi","year":"2009","unstructured":"Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L (2009) 2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections. Eur Urol Suppl 8:453\u2013457","journal-title":"Eur Urol"},{"key":"969_CR9","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","volume":"85","author":"L Cheng","year":"1999","unstructured":"Cheng L, Cheville JC, Neumann RM (1999) Survival of Patients with Carcinoma In Situ of the Urinary Bladder. Cancer 85:2469\u20132474","journal-title":"Cancer"},{"key":"969_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canlet.2006.10.011","volume":"250","author":"R Gonzalez-Campora","year":"2007","unstructured":"Gonzalez-Campora R, Davalos-Casanova G, Beato-Moreno A, Lopez-Beltran A (2007) BCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinoma. Cancer Lett 250:292\u2013299","journal-title":"Cancer Lett"},{"key":"969_CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.urolonc.2007.12.011","volume":"27","author":"ON Gofrit","year":"2009","unstructured":"Gofrit ON, Pode D, Pizov G (2009) The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-G\u00faerin immunotherapy. Urol Oncol 27:258\u2013262","journal-title":"Urol Oncol"},{"key":"969_CR12","first-page":"147","volume":"Suppl 157","author":"H Wolf","year":"1994","unstructured":"Wolf H, Melsen F, Pedersen SE, Nielsen KT (1994) Natural history of carcinoma in situ of the urinary bladder Scand. J Urol N\u00e9phrol Suppl 157:147\u2013151","journal-title":"J Urol N\u00e9phrol"},{"key":"969_CR13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0022-5347(05)66333-1","volume":"165","author":"J Palou","year":"2001","unstructured":"Palou J, Laguna P, Millan-Rodriguez F, Hall RR, Salvador-Bayarri J, Vicente-Rodriguez J (2001) Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and\/or high grade bladder tumors. J Urol 165:1488\u20131491","journal-title":"J Urol"},{"key":"969_CR14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.eururo.2003.12.013","volume":"45","author":"MJ Ribal","year":"2004","unstructured":"Ribal MJ, Alcaraz A, Mengual L (2004) Chromosomal High-Polysomies Predict Tumour Progression in T1 Transitional Cell Carcinoma of the Bladder. Eur Urol 45:593\u2013599","journal-title":"Eur Urol"},{"key":"969_CR15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0090-4295(03)00236-X","volume":"61","author":"SF Shariat","year":"2003","unstructured":"Shariat SF, Kim J, Raptidis G, Ayala GE, Lerner SP (2003) Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61:1140\u20131145","journal-title":"Urology"},{"key":"969_CR16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0002-9440(10)64388-X","volume":"161","author":"AH Hopman","year":"2002","unstructured":"Hopman AH, Kamps MA, Speel EJ, Schapers RF, Sauter G, Ramaekers FC (2002) Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am J Pathol 161:1119\u20131125","journal-title":"Am J Pathol"},{"key":"969_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(00)00892-X","volume":"57","author":"SF Shariat","year":"2001","unstructured":"Shariat SF, Pahlavan S, Baseman AG (2001) E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57:60\u201365","journal-title":"Urology"},{"key":"969_CR18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","volume":"161","author":"AR Zlotta","year":"1999","unstructured":"Zlotta AR, Noel JC, Fayt I (1999) Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol 161:792\u2013798","journal-title":"J Urol"},{"key":"969_CR19","first-page":"809","volume":"62","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Schlake G, Zaak D (2002) Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 62:809\u2013818","journal-title":"Cancer Res"},{"key":"969_CR20","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","volume":"64","author":"L Dyrskj\u00f8t","year":"2004","unstructured":"Dyrskj\u00f8t L, Kruh\u00f8ffer M, Thykjaer T (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64:4040\u20134048","journal-title":"Cancer Res"},{"key":"969_CR21","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/ijc.24619","volume":"125","author":"K Zieger","year":"2009","unstructured":"Zieger K, Marcussen N, Borre M, Orntoft TF, Dyrskj\u00f8t L (2009) Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development. Int J Cancer 125:2095\u20132103","journal-title":"Int J Cancer"},{"key":"969_CR22","first-page":"2893","volume":"28","author":"A Lopez-Beltran","year":"2008","unstructured":"Lopez-Beltran A, Cheng L, Mazzucchelli R, Blanca A, Montironi R (2008) Morphological and Molecular Profiles and Pathways in Bladder Neoplasms. Anticancer Res 28:2893\u20132900","journal-title":"Anticancer Res"},{"key":"969_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2005.12.041","volume":"50","author":"BP Schrier","year":"2006","unstructured":"Schrier BP, Vriesema JL, Witjes JA, Kiemeney LA, Schalken JA (2006) The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma. Eur Urol 50:76\u201382","journal-title":"Eur Urol"},{"key":"969_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/path.1952","volume":"209","author":"A Lopez-Beltran","year":"2006","unstructured":"Lopez-Beltran A, Requena MJ, Luque RJ, Alvarez J, Montironi R (2006) Cyclin D3 expression in primary Ta\/T1 bladder cancer. J Pathol 209:106\u2013113","journal-title":"J Pathol"},{"key":"969_CR25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2003.11.011","volume":"45","author":"A Lopez-Beltran","year":"2004","unstructured":"Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Montironi R (2004) Prognostic Factors in StageT1Grade 3 Bladder Cancer Survival: The Role of G1\u2009+\u2009S Modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and Proliferation Index (ki67-MIB1). Eur Urol 45:606\u2013612","journal-title":"Eur Urol"},{"key":"969_CR26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<323::AID-IJC8>3.0.CO;2-1","volume":"65","author":"J Bartkova","year":"1996","unstructured":"Bartkova J, Zemanova M, Bartek J (1996) Abundance and subcellular localization of cyclin D3 in human tumors. Int J Cancer 65:323\u2013327","journal-title":"Int J Cancer"},{"key":"969_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2009.09.013","volume":"57","author":"M Birkhahn","year":"2010","unstructured":"Birkhahn M, Mitra AP, Williams AJ (2010) Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol 57:12\u201320","journal-title":"Eur Urol"},{"key":"969_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1078-0432.242.11.1","volume":"11","author":"G Pruneri","year":"2005","unstructured":"Pruneri G, Pignataro L, Valentini S (2005) Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma. Clin Cancer Res 11:242\u2013248","journal-title":"Clin Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0969-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-0969-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0969-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:48:45Z","timestamp":1685771325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-0969-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-0969-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}